FDA OKs 1st drug to treat smallpox, in case of terror attack

FDA OKs 1st drug to treat smallpox, in case of terror attack
This 1975 microscope image made available by the Centers for Disease Control and Prevention shows a cluster of smallpox viruses. On Friday, July 13, 2018, U.S. regulators announced the approval of the first treatment for smallpox—a deadly disease that was wiped out four decades ago—in case the virus is used in a terror attack. (Fred Murphy/CDC via AP)

U.S. regulators Friday approved the first treatment for smallpox—a deadly disease that was wiped out four decades ago—in case the virus is used in a terror attack.

Smallpox, which is highly contagious, was eradicated worldwide by 1980 after a huge vaccination campaign.

But people born since then haven't been vaccinated, and small samples of the were saved for research purposes, leaving the possibility it could be used as a .

Maker SIGA Technologies of New York has already delivered 2 million treatments that will be stockpiled by the government, which partially paid for the development of the drug, called TPOXX.

To test the drug's effectiveness, monkeys and rabbits were infected with a similar virus and then given the drug. More than 90 percent survived, the company said. Its safety was tested in several hundred healthy volunteers, who were not infected with .

Smallpox killed about 300 million people worldwide in the 20th century before its eradication. Symptoms include fever, fatigue and pus-filled sores. Until now, doctors could only provide supportive care such as IV fluids and fever remedies and isolate the patients. Vaccination can be used to prevent infection but it must be done within five days of exposure to the , well before symptoms appear.

FDA OKs 1st drug to treat smallpox, in case of terror attack
This undated photo provided by SIGA in July 2018 shows capsules of the drug TPOXX. On Friday, July 13, 2018, U.S. regulators announced the approval of the first treatment for smallpox—a deadly disease that was wiped out four decades ago—in case the virus is used in a terror attack. (SIGA via AP)
"This new treatment affords us an additional option should smallpox ever be used as a bioweapon," Dr. Scott Gottlieb, head of the Food and Drug Administration, said in a statement.

The drug is a capsule, taken twice daily for 14 days.

SIGA develops vaccines and medicines for biological, chemical, radiological and nuclear attacks. Chief Executive Phil Gomez said the company is developing an IV version and is exploring selling the to other countries and developing it to treat other infectious diseases, including monkeypox, which African monkeys can transmit to humans. Monkeypox can then spread among people, and has a mortality rate of about 15 percent.


Explore further

Compound in red wine, chocolate prevents smallpox virus cousins from replicating

© 2018 The Associated Press. All rights reserved.

Citation: FDA OKs 1st drug to treat smallpox, in case of terror attack (2018, July 14) retrieved 21 February 2019 from https://medicalxpress.com/news/2018-07-fda-oks-1st-drug-smallpox.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more